Description
IGF::CT::IGF OPTION YEAR 2 RADIOPHARMACEUTICAL COMPOUNDING CHANGE ADMIN CO
Modification chain · 4 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2014-10-01+$712,184= $712,184
- Mod P000012015-03-23-$40,000= $672,184
- Mod P000022015-06-26-$75,000= $597,184
- Mod P000032015-08-27-$33,682= $563,502
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2014-10-01 | +$712,184 | $712,184 | IGF::CT::IGF OPTION YEAR 2 RADIOPHARMACEUTICAL COMPOUNDING CHANGE ADMIN CO |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2015-03-23 | −$40,000 | $672,184 | IGF::CT::IGF OPTION YEAR 2 RADIOPHARMACEUTICAL COMPOUNDING CHANGE ADMIN CO |
| Mod P00002· FUNDING ONLY ACTION | 2015-06-26 | −$75,000 | $597,184 | IGF::CT::IGF OPTION YEAR 2 RADIOPHARMACEUTICAL COMPOUNDING CHANGE ADMIN CO |
| Mod P00003· FUNDING ONLY ACTION | 2015-08-27 | −$33,682 | $563,502 | IGF::CT::IGF OPTION YEAR 2 RADIOPHARMACEUTICAL COMPOUNDING CHANGE ADMIN CO |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI CWN9UGL3NCL9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24226N0711 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 3650 · CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY | $100,008 | FY2026 |
| 36C24126P0328 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $999,797 | FY2026 |
| 36C25726N0407 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $1,400,000 | FY2026 |
| 36C25526N0361 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $228,679 | FY2026 |
| 36C24426N0938 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $650,641 | FY2026 |
| 36C24426D0097 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
Other recipients under Q517 from 614-MEMPHIS (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24914J0094 | MEDICAL ALTERNATIVE'S | 614-MEMPHIS | $240,000 | FY2014 |
| VA24913P1318 | CARDINAL HEALTH 200, LLC | 614-MEMPHIS | $47,478 | FY2013 |
| VA24913P1326 | TRIAD ISOTOPES, INC. | 614-MEMPHIS | $43,092 | FY2013 |
| VA24913F0958 | AHS STAFFING LLC | 614-MEMPHIS | $31,669 | FY2013 |
| VA24913F0831 | GLC ON-THE-GO, INC. | 614-MEMPHIS | $74,640 | FY2013 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24915J3426_3600_VA24913D0090_3600 · retrieved 2026-09-26.